InvestorsHub Logo
Followers 4
Posts 63
Boards Moderated 0
Alias Born 09/22/2020

Re: A deleted message

Thursday, 04/01/2021 3:28:47 AM

Thursday, April 01, 2021 3:28:47 AM

Post# of 233624
Some people have said we didn’t know about dosing and that’s what went wrong because it was early and not the fault of FDA. Apparently on the Oct 20th CC, I’ll give NP credit here per one YMB poster who remembered and you’ll know why the FDA is corrupt:

Min 11:45 @ Oct. 20th, 2020 CC.
Can be found in the IR Calendar link on the website:

" As Nader said, there was the DSMC meeting last Thursday
and during the the intro to the meeting, I had asked the members of the committee
to look @ the clinical signals, mortality signals and to specifically address weather we
needed to adjust the dosing. When we had submitted CD10 & CD12, we had proposed
2 doses for the mild to moderate patients, 4 doses for the severe & critical & the FDA
pushed back having to give 2 doses for both study populations. I've never actually been
comfortable with that, and so the question i asked the committee was, was there a signal
that might require Cytodyn to adjust the CD12 dosage. Are there patients who, particularly
critical patients, who might need a 3rd or 4th dose of Leronlimab ?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News